Fundamentals and developments in fluorescence-guided cancer surgery

J Sven D Mieog1, Friso B Achterberg1,2, Aimen Zlitni2

  • 1Department of Surgery, Leiden University Medical Center, Leiden, Netherlands.

Insights

Fluorescence-guided surgery uses targeted imaging agents for real-time intraoperative cancer detection. Optimizing this approach requires seamless integration of targets, agents, and systems to improve patient outcomes.

Area of Science:

  • Oncology
  • Medical Imaging
  • Surgical Technology

Background:

  • Fluorescence-guided surgery (FGS) is a rapidly advancing technique for intraoperative cancer detection.
  • Numerous fluorescently labeled molecules targeting cancer hallmarks have been developed.
  • Translating these agents into clinical practice faces challenges, with few reaching advanced trials.

Purpose of the Study:

  • To review the key aspects of the fluorescence-guided surgery imaging cascade.
  • To focus on imaging approaches and methods enhancing intraoperative visualization.
  • To highlight advancements aimed at improving patient outcomes in cancer surgery.

Main Methods:

  • Review of current literature on fluorescence-guided surgery.
  • Analysis of imaging agents, target selection, and detection systems.
  • Discussion of clinical implementation strategies for intraoperative visualization.

Main Results:

  • Development of diverse fluorescent imaging agents targeting cancer hallmarks.
  • Identification of critical factors for successful clinical translation of FGS.
  • Emerging approaches for real-time intraoperative visualization.

Conclusions:

  • Successful clinical implementation of FGS depends on harmonized target selection, imaging agents, and detection systems.
  • Continued research and development are crucial for advancing FGS.
  • The ultimate goal is to improve patient outcomes through enhanced intraoperative cancer detection.